Principal Investigator
David Kerman
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20221084
Clinical Trial Summary
A randomized, double-blind, controlled, multi-center study to evaluate the efficacy and safety of dose de-escalation of orally administered Filgotinib in subjects with ulcerative colitis in clinical remission.
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Gastrointestinal, Stomach, Esophageal
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu